Research
Hormonal
Thiazolidinediones and metformin are insulin-sensitizing pharmacological agents that can treat NAFLD by reducing insulin resistance in the liver and periphery, respectively.
If you have fatty liver, doctors may prescribe insulin-sensitizing drugs like metformin or thiazolidinediones to help reduce liver fat and improve metabolic health by targeting insulin resistance.
GoodSupportsHIGH confidence
Finally, the ability of insulin-sensitizing, pharmacological agents to treat NAFLD by reducing IR in the liver (metformin) and in the periphery (thiazolidinediones) are discussed.
Why this rating
The paper reviews clinical evidence and mechanisms for these drugs.
Source
Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *
Elisabetta Bugianesi et al. · Hepatology · 2005
DOI 10.1002/hep.20920
narrative_reviewCited 889×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Insulin resistance drives nonalcoholic fatty liver disease (NAFLD) progression through increased free fatty acid flux from adipose tissue to the liver, leading to hepatic triglyceride accumulation and impaired glucose metabolism.Good
- Adiponectin levels are negatively correlated with liver fat and hepatic insulin resistance, and low levels are associated with more extensive necroinflammation in NAFLD.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →